Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

NCR Voyix to Release Fourth Quarter and Full Year 2023 Earnings Results on February 29, 2024


NCR Voyix Corporation (NYSE: VYX), a leading provider of technology solutions, will publish consolidated financial results for the fourth quarter and full year 2023 after the market closes on February 29, 2024. NCR Voyix's management team will host a conference call to discuss the results at 4:30 p.m. EST the same day.

Conference Call Details

Participants should join 15 minutes before the start and request the "NCR Voyix Fourth Quarter and Full Year 2023 Earnings Call."

A live webcast of the conference call and related presentation materials will be available on the company's investor relations website at https://investor.ncrvoyix.com. A replay of the webcast will be available on the company's investor relations website following the live event.

About NCR Voyix

NCR Voyix Corporation (NYSE: VYX) is a leading global provider of digital commerce solutions for the retail, restaurant and digital banking industries. NCR Voyix transforms retail stores, restaurant systems and digital banking experiences with comprehensive, platform-led SaaS and services capabilities. NCR Voyix is headquartered in Atlanta, Georgia, with approximately 15,000 employees and customers in 35 countries.

Web site: www.ncrvoyix.com
X: @NCR_Voyix
Facebook: www.facebook.com/ncrcorp
Instagram: www.instagram.com/ncrvoyix
LinkedIn: www.linkedin.com/company/ncrvoyix
YouTube: www.youtube.com/user/ncrvoyix


These press releases may also interest you

at 21:05
DTEN's Next Generation Video Conferencing and Collaboration Device for Zoom and Microsoft Teams, Now available in South Korea
DTEN, a leading provider of video conferencing solutions, is proud to announce that their flagship All-in-One solution, the DTEN D7X series, is now available to purchase in South Korea after it has successfully passed the rigorous certification...

at 20:15
AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer's Disease (POLARIS-AD)
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...

at 18:47
Canton Fair and Guangzhou Branch of the National Archives of Publications and Culture Forge Deep Collaboration with Design Innovation Award
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...

at 17:11
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
Shanghai Electric (SEHK:2727, SSE:601727) announced that the Company...

at 15:40
Brooks Breland Named Leading Lawn and Plant Health Care Expert
Sexton Lawn & Landscapes is thrilled to announce the appointment of Brooks Breland as the leading Lawn and Plant Health Expert. In this role, Breland will...

at 13:05
Seventh Annual Chinese Costume Festival Merges Hanfu Tradition with Contemporary Fashion
From April 20 to 21, 2024, China National Silk Museum hosted the seventh annual Chinese Costume Festival, under the theme "Ancient Charm, Modern Style." This event aimed to rejuvenate traditional cultural practices and artifacts, making them resonate...

More news about Science and technology...


News published on and distributed by: